Common questions about Despa (FAQ)
Q: Why is Despa usually taken for a long time?
A: Regulatory documents state that Despa is intended strictly for short-term use. Official guidance specifies that the duration of application should generally not exceed 7 consecutive days. This duration limit is a required element of the official product labeling.
Q: Do I need to stop taking Despa if I feel better?
A: The product is designed for short-term, acute symptomatic management. Official labeling restricts the treatment course to not exceeding 7 consecutive days. This maximum duration is specified in the regulatory labeling for the management of acute symptoms.
Q: Is Despa available in different strengths?
A: The topical and mucosal preparations contain specific, defined concentrations of the two active ingredients, Chlorhexidine Gluconate and Diphenhydramine. These concentrations are stated in the official product labeling to ensure consistency and correct use for the specified routes of administration.
Q: What is the inactive ingredient in Despa tablets?
A: Official documents, such as the Prescribing Information, are required to contain a full list of all ingredients, including the inactive ingredients (excipients) used in the formulation. This information is available in the detailed product description.
Q: Why do some people say Despa causes trouble sleeping?
A: Official safety information notes that the Diphenhydramine component is a first-generation antihistamine that may cause systemic effects. The documented systemic effect is sedation (drowsiness), which is typically associated with sleepiness.
Q: Does alcohol interact with Despa?
A: Yes, regulatory information documents that co-use with alcohol results in additive central nervous system (CNS) depressant effects due to the Diphenhydramine component. This means the sedative effects of both substances can be enhanced when used together.
Q: Why do official documents mention liver function tests for Despa?
A: Official labeling advises caution for patients with pre-existing liver or kidney impairment. This necessity for caution is related to the professional oversight required when these conditions are present.
Q: Does Despa cause dry mouth?
A: The Diphenhydramine component acts as an antagonist at muscarinic acetylcholine receptors, which may be associated with anticholinergic effects. Anticholinergic effects are known to include the feeling of dry mouth, which is often reported with medications that have this pharmacological action.
Q: Why does the Despa leaflet mention driving restrictions?
A: Driving restrictions are generally included in leaflets based on the documented systemic safety profile of the drug. These restrictions are specifically related to the potential effects of the Diphenhydramine component, which include dizziness and sedation that could impair alertness and coordination.
Q: How quickly should I expect Despa to start working?
A: The speed of noticeable effect varies depending on the two active components and the route of administration (topical or mucosal). Information regarding the time it takes for the effects to begin is addressed in the pharmacodynamics section of the official product information.
Q: Are there any specific foods or drinks to avoid while using Despa?
A: The regulatory labeling specifies a mandatory separation period between using the oral liquid formulation and eating, drinking, or toothbrushing. This regulatory separation period is necessary to maintain the intended local therapeutic effect of the rinse.
Q: Can older adults use Despa?
A: Official documents advise caution for older adults due to the potential for increased sensitivity to the sedative effects of the antihistamine component. The labeling advises that the minimum effective frequency be utilized for the application in this population.
Q: Do interactions with other drugs mean I absolutely cannot take them together?
A: Official documents clarify the difference between strict contraindications (prohibited combinations, such as MAOIs) and other interactions. Other interactions, like those with alcohol, require only caution, timing separation, or consideration of additive effects.
Q: What happens when you stop using Despa?
A: Since the product is used for localized, symptomatic management, when the use is discontinued, the effects of the anti-infective and symptom-relief components will cease. This may result in the recurrence of the localized symptoms the product was used to manage.
Q: Is Despa a controlled substance?
A: Official classifications and government regulatory schedules do not list this combination product as a controlled substance.
Q: Is Despa approved in Europe (EMA) for the same things as in the US (FDA)?
A: The specific indications (approved uses) for Despa may vary between different regulatory bodies, such as the US FDA and the European EMA. These approved uses are specifically detailed in each country's official labeling or summary of product characteristics (SmPC).
Q: How long does Despa stay in your system after the last dose?
A: Information regarding the half-life and clearance (how long it takes for the drug to leave the system) of the active ingredients is documented in the pharmacokinetic section of the official product information.
Q: Is there a risk of dependency or addiction with Despa?
A: The Diphenhydramine component, which is a first-generation antihistamine, has been associated with reports of misuse or dependence when absorbed systemically. This safety information is included in the official warnings and precautions section.
Q: Are generic versions of Despa available?
A: Information regarding the availability of generic or therapeutically equivalent versions of this combination product is tracked by regulatory agencies such as the FDA. Such agencies publish documentation detailing approved equivalents.
Q: What should be checked before someone starts taking Despa?
A: Official labeling outlines specific contraindications, such as a known hypersensitivity to the active ingredients. It also lists conditions that require caution, including liver or kidney impairment and certain eye or urinary conditions. These factors are part of the considerations outlined in the official labeling.
Q: Can Despa be crushed or split?
A: The product is specifically manufactured and specified as a liquid or topical preparation (gel, cream, or rinse). Since the product is specified as a liquid or topical preparation, instructions for crushing or splitting solid dosage forms do not apply.
Q: Are there common misunderstandings about what Despa treats?
A: Because Despa has a dual composition—an antiseptic (Chlorhexidine) and an antihistamine (Diphenhydramine)—it often leads to questions about its full scope of use. Regulatory agencies define its purpose as providing combined localized antimicrobial action and symptom relief.
Q: Is Despa related to any other well-known drug names?
A: Despa is a combination product containing two active ingredients that are both established drugs used individually. These ingredients are Chlorhexidine Gluconate (an antiseptic) and Diphenhydramine (an antihistamine).
